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Abstract
Light absorption by macular pigment may attenuate visual discomfort, or photophobia, for targets composed of short-wavelength
light. Macular pigment optical density (MPOD) and photophobia light thresholds were measured psychophysically in 10 subjects. The
energy necessary to induce photophobia for a short-wavelength target relative to a long-wavelength target was linearly related to MPOD,
as well as estimates of peak MPOD and integrated macular pigment. In four subjects who consumed lutein supplements, increases in
MPOD corresponded to increases in photophobia light thresholds. Light absorption by macular pigment appears to inXuence the amount
of short-wavelength light necessary to elicit photophobia.
© 2006 Elsevier Ltd. All rights reserved. 
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In the human eye, some short-wavelength light is
absorbed by macular pigment before it reaches the photo-
pigments in the central retina. The macular pigment, com-
prised primarily of two dietary carotenoids, lutein and
zeaxanthin, absorbs wavelengths of light between 400 and
530 nm (Wyszecki & Stiles, 1982). The absorption of radi-
ant energy by macular pigment may protect posterior ocu-
lar tissue from excessive exposure of potentially harmful
wavelengths of light. At wavelengths of light below 450nm,
for example, approximately one-hundred times less energy
is needed to produce retinal insult compared to wave-
lengths greater than 590 nm (Ham, Mueller, & Sliney, 1976).
Light absorption by macular pigment may also aVect light
thresholds for visual discomfort or photophobia.
Photophobia is a condition characterized by the
exacerbation or generation of pain or discomfort as a
 This article presents Wndings from Adam J. Wenzel’s doctoral disserta-
tion research conducted at the University of New Hampshire.
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viduals experience an acute episode of photophobia as they
enter a bright environment after prolonged exposure to
dark surroundings, some individuals suVer from chronic
light-induced pain. Patients with neurological disorders,
such as trigeminal neuralgia (WolV, 1963), and individuals
suVering from eye diseases, like retinitis pigmentosa (Gaw-
ande, Donovan, Ginsburg, & Marmor, 1989) and age-
related macular degeneration (Bacotti, 2001), may report
persistent hyper-sensitivity to light and periods of photo-
phobia. Photophobia also appears to be a common symp-
tom of migraine headaches (Drummond, 1997;Muelleners
et al., 2001; Vanagaite-Vingen & Stovner, 1998). Despite its
association with numerous clinical conditions, little is
known about the etiology of photophobia other than the
involvement of the trigeminal pupillary reXex (Lebensohn,
1951).
Most research investigating the stimulus parameters
mediating visual discomfort focused on discomfort
glare—a condition in which distracting, possibly discom-
forting, light sources are located in the peripheral Weld of
view (Vos, 2003). Using a standardized scale (de Boer,
1967), Sivak, Flannagan, Traube, and Kojima (1999) found
4616 A.J. Wenzel et al. / Vision Research 46 (2006) 4615–4622that as the duration or intensity of a light source
increased, so did observers’ levels of visual discomfort.
Other investigators have reported that discomfort thresh-
olds were lower for binocular, versus monocular, targets
(Vanagaite et al., 1997;Vanagaite-Vingen & Stovner,
1998) and non-uniform or grating, versus uniform, stim-
uli (Waters, Mistrick, & Bernecker, 1995). Berman, Bulli-
more, Jacobs, Bailey, and Gandhi (1994) demonstrated
that eye squinting magnitude, as measured by electromy-
ography (EMG), was related to a subject’s level of visual
discomfort. For a glare source located at 11° retinal
eccentricity, they found that muscle contraction around
the eye increased as the luminance of the light source
increased. Further, their subjects appeared to experience
more discomfort when viewing a 2° glare source than a 1°
source.
Several investigators looked at the eVects of a target’s
spectral composition on visual discomfort. Berman and
colleagues (1996), for example, reported that a light
source weighted in energy toward the long-wavelength
end of the spectrum induced greater discomfort (i.e., mus-
cle contraction) compared to a light weighted in energy
at the shorter wave end. In patients with migraine, Main,
Vlachonikolis, and Dowson (2000) found that discomfort
thresholds were lower for a short-wavelength target than
for a medium or long-wavelength target. Discomfort
thresholds for the short and long-wavelength targets were
similar in the control group, and lower than the threshold
for a medium-wavelength target. More recently, String-
ham, Fuld, and Wenzel (2003) looked at the eVects of
monochromatic lights (with bandwidths less than 10 nm)
on photophobia thresholds. Unlike other researchers,
they controlled retinal illuminance (pupil size) by using
Maxwellian view optics. Stringham et al., used both
EMG and a rating scale to measure photophobia thresh-
olds for wavelengths of light between 440 and 640 nm.
The normalized action spectra for all of their observers
showed a high degree uniformity. Between 520 and
640 nm, there was a positive relationship between wave-
length and the energy needed to produce photophobia.
At shorter wavelengths the spectra show a notch centered
at 460 nm. Interestingly, the trough and shape of this
notch roughly resemble the log transmittance spectrum
of macular pigment. In fact, the diVerence in macular pig-
ment optical density (MPOD) among the subjects
appeared to account for their slight, but uniform, diVer-
ence in photophobic sensitivity below 520 nm. Further,
when the Wltering eVects of macular pigment, as well as
the lens, were accounted for, the photophobia spectra
resembled the retinal damage function reported by Ham
et al. (1976). These Wndings suggest that macular pigment
may attenuate photophobia or discomfort associated
with suYciently intense short-wavelength targets and
may impact the threshold for photophobia under normal
viewing conditions. The objective of the present project
was to test directly the relationship between macular pig-
ment and photophobia light threshold.2. General methods
2.1. Measurement of macular pigment optical density
Retinal sensitivity to a short-wavelength light was measured in the
fovea and parafovea with heterochromatic Xicker photometry (HFP). For
a given trial the subject viewed one of four centrally Wxated targets or a
parafoveal target. The four centrally Wxated targets were two discs, with
visual angles of 40 and 60 of arc, and two annuli, with widths of 20 and
outer diameters of 2° and 4° of arc. The parafoveal target was a 2° disc
centered at 7° eccentricity by the subject’s Wxation of a small, long-wave-
length point of light. The spatial distributions of the Wve targets relative to
MPOD across the fovea are illustrated in Fig. 1 (top panel). Each target
was superimposed on a 6°, 470 nm background (1.5 log Tds), and alter-
nated in square-wave between a 460 nm test light and a 550 nm reference
light (1.7 log Tds); the half-bandwidth of the background, reference and
Fig. 1. Schematic of the spatial distributions of the stimuli used to measure
macular pigment optical density (MPOD; top panel) and photophobia
thresholds (bottom panel) relative to MPOD. In the top panel, Stimuli A
and B are centrally Wxated discs that subtend 40 and 1° of visual angle,
respectively. Stimuli C and D are centrally Wxated annuli, with outer edges
subtending 2° and 4°, respectively. The widths of the annuli subtend 20 of
visual angle. Stimulus E is a 2° disc centered at 7° eccentricity by the sub-
ject’s Wxating a small point of light to the left of the stimulus. Subtracting
the mean log energy necessary to minimize or eliminate Xicker for target E
from the mean log energy necessary for the four centrally viewed targets
yields measures of MPOD at 20 (A), 30 (B), 1° (C), and 2° (D) eccentric-
ity. In the bottom panel, Stimuli F and G are discs subtending 8.2° of
visual angle. Stimulus F is centrally Wxated whereas stimulus G is centered
at 10.1° eccentricity by the subject’s Wxation of a small point of light. Sub-
tracting the ratio of energy necessary to induce photophobia for Stimulus
G from the energy ratio necessary for Stimulus F yields a diVerence ratio
or photophobia ratio.
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Macular Metrics® (Rehoboth, MA), free-view densitometer described by
Wooten, Hammond, Land, and Snodderly (1999).
The radiance of the reference light was kept constant as the subject
adjusted the radiance of the test light in order to minimize or eliminate the
perceived Xicker of the test stimulus. The variation in combined radiance
with adjustment of the test light does not eVect Xicker photometric mea-
surements of this sort (Kaiser & Boynton, 1996). Likewise, the Xicker fre-
quency of the test target has little impact on the measure provided the
subject can Wnd a point of minimal or zero Xicker (Werner, Donnelly, &
Kliegl, 1987). Ideally, the subject should be able to adjust the intensity of
the test light to observe a “zone” of Xicker on both sides of a small null
zone—range of radiances for which the test stimulus appears not to Xicker.
The subject’s speciWc task was to Wnd the null zone and then estimate its
mid point. Typically, a subject’s estimate of the mid point for a particular
target varies slightly between and within testing sessions. One method to
reduce such variability is to adjust the Xicker frequency of the test stimulus
until the null zone is small (Hammond, Wooten, & Smollon, 2005). In gen-
eral, the null zone and Xicker frequency are related positively, such that
increasing the Xicker frequency increases the null zon’e. In the current pro-
ject, the Xicker frequency of each target was adjusted until the subject per-
ceived a null zone that spanned 100 radiance units according to the
instrument’s readout. A null zone of this size was small enough to limit
subject variability, but large enough so that subjects could easily and
consistently perform estimations of the null zone’s mid point. The Xicker
frequencies used in the current project ranged between 15 and 21 Hz for
the foveal targets and between 10 and 13 Hz for the parafoveal target.
Regardless of the size of the null zone, subjects rarely select the exact same
mid-point on successive attempts. In order to reduce the eVects of such
variability, eight mid-point estimations were obtained for each target.
After the subject selected each mid-point by depressing a button, the radi-
ance of the test light was oVset between 100 and 300 radiance units either
above or below the mid-point radiance. The mean radiance of the eight
measures was used to calculate MPOD at each eccentricity. More speciW-
cally, the mean log radiance of the eight parafoveal mid-points was sub-
tracted from the mean log radiance of each of the four foveal targets to
yield measures of MPOD at the four retinal loci where the edges of the
centrally Wxated targets were imaged (Werner et al., 1987): 20, 30, 1°, and
2° eccentricity.
An estimate of aggregate light Wltration by macular pigment across the
fovea was estimated by taking the area under each subject’s measures of
MPOD, or MPOD proWle. Each subject’s data was plotted and Wt with a
Gaussian function using Origin 7.0 (Origin Lab Corporation, Northamp-
ton, MA). The area under each subject’s Wtted MPOD proWle was taken to
yield a measure of integrated macular pigment screening. The nonlinear
function also provided an estimate of peak MPOD (i.e., MPOD at 0°).
2.2. Measurement of photophobia
Photophobia thresholds were measured in Maxwellian-view using a
method similar to Stringham, Fuld, and Wenzel (2004). In short, a three-
channel Maxwellian view optical system was used to produce the test stim-
uli. One channel was used to produce an 8.2°, broadband test stimulus.
Light in this channel passed through either a broadband short-wavelength
Wlter (Oriel Corp. #59830), which transmitted wavelengths of light less
than 520 nm, or a broadband long-wavelength Wlter (TiVen #15), which
transmitted light at wavelengths above 540 nm. Thus, light transmitted by
the short-wavelength Wlter was strongly absorbed by the macular pigment,
whereas the light transmitted by the long-wavelength Wlter was outside the
absorption spectrum of macular pigment. Another channel was used to
create a mesopic (¡1 log cd/m2), xenon-white, 30.5° background. The third
channel produced a small, 20, long-wavelength Wxation light.
At the beginning of each experimental session, the subject’s right pupil
was aligned with the exit pupil of the optical system. Throughout the exper-
iment a dental impression and forehead rests were used by the subject to
maintain this position. After the alignment procedure, subjects dark
adapted for 20 min. Subjects then Wxated the small long-wavelength light
for 2 min. This Wxation light was located either centrally, for foveal mea-sures of photophobia, or at 10.1° temporal eccentricity for parafoveal mea-
sures of photophobia. Fig. 1 (bottom panel) shows the spatial distributions
of the foveal and parafoveal test stimuli relative to MPOD. After the sub-
ject adapted to the background for 2 min, the experimenter announced that
the test stimulus was to be presented. The time between the experimenter’s
cue and the presentation of the test target was quasi-random, between 5
and 20 s. After a 5-s presentation of the test target, subjects used a 10-point
psychophysical scale, similar to the de Boer scale (de Boer, 1967) to rate
their level of visual discomfort. A “1” represented no discomfort and a “10”
represented photophobia—i.e., the light caused suYcient discomfort to
elicit a squint and subjects’ desire to divert their eye from the target. The
initial test target was well below a subject’s photophobia threshold. By use
of the method of ascending limits, the energy of the test light was increased
by subtracting neutral density from the test stimulus channel. If the subjects
rated their discomfort between 5 and 9, 0.1 log units of neutral density were
subtracted; otherwise 0.3 log units were removed from the channel. Ran-
dom catch trials were performed in the following way to assess subject bias.
After each presentation of the test stimulus, the experimenter rolled two die.
If the sum of the die was 2, 0.1 log units of density were added to the test
channel. If the subject correctly rated the stimulus as less intense (i.e., gave a
lower number) than the previous target, the response was recorded as a
“hit.” Conversely, if the subject incorrectly rated the stimulus, rating it as
equally or more discomforting than the previous stimulus, it was recorded
as a “false alarm” (FA). Additional non-random catch trials were also per-
formed by the experimenter to determine better subjects’ photophobia
thresholds. To maintain the same level of retinal sensitivity prior to each
presentation of the test stimulus, subjects covered their right-eye with an
eyepatch and dark adapted for 15 min between trials. This amount of time
ensured that the subject was able to perceive the mesopic background. The
above procedure was repeated until the subject reported that he or she
experienced photophobia (i.e., a rating of 10) while viewing the test stimu-
lus. Photophobia thresholds for the 8.2° test stimulus were measured for the
short-wavelength (“blue”) target in the fovea and parafovea and for the
long-wavelength (“orange”) target in the fovea and parafovea. All four
light thresholds were measured in a single experimental session. After the
experiment, the relative energy of the four test lights that induced photo-
phobia, which ranged between 4.06 and 4.98 log Tds, was measured using a
radiometer (United Detector Technology Optometer #61). The log relative
energy of the orange target that induced photophobia was then subtracted
from the log relative energy of the blue target that induced photophobia to
yield a foveal photophobia ratio. A parafoveal photophobia ratio was cal-
culated in the same manner. Finally, a diVerence ratio (PP ratio) was calcu-
lated by taking the absolute diVerence between the parafoveal photophobia
ratio and the foveal photophobia ratio. For example, the log relative ener-
gies of the orange and blue foveal targets rated a 10 (i.e., induced photopho-
bia) by Subject 1 were 2.158 and 2.174, respectively, yielding a fovea
photophobia ratio of ¡0.016. The log relative energies that induced photo-
phobia in parafovea of Subject 1 were 2.451 for the orange target and 2.238
for the blue target, yielding a parafoveal photophobia ratio of ¡0.673. The
resulting diVerence ratio, or PP ratio, for Subject 1 was 0.657. The fovea and
parafovea ratios used in this example are illustrated in Fig. 2 by the slashed
bars (scaling technique) for Subject 1 and were obtained in the following
pilot study.
2.3. Validation of scaling procedure
Prior to the initiation of the project, a pilot study was conducted to
compare photophobia thresholds measured with the scaling technique to
those determined with EMG. Most previous studies investigating visual
discomfort asked subjects to use a scale (as was the case in the present
study) to quantify their level of discomfort when viewing a light source. A
few researchers, however, attempted to measure photophobia or discom-
fort glare using an objective, EMG procedure (Berman et al., 1994; Mur-
ray, Plainis, & Carden, 2002; Stringham et al., 2003). They recorded gross
muscle potentials around the eye (EMG) while their subjects viewed a light
source. Essentially, these researchers assumed that a suYciently intense
light will compel a subject to squint in order to limit the amount of light
entering the eye. When the signal-to-noise ratio of the EMG trace (i.e.,
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ationally to have experienced photophobia. The subjects in these studies
were also asked to rate their level of discomfort using a scale. Interestingly,
the three groups of researchers noted a high degree of correspondence
between squint magnitude and the subjects’ subjective ratings of discom-
fort. In fact, Stringham et al., showed that the photophobia action spec-
trum obtained using EMG looked essentially identical to the spectrum
based on their subjects’ ratings of lights just below the photophobia
threshold. Their subjects used the same 10-point psychophysical scale used
in the present study. As a way to further validate the scaling procedure
used in the present study, the EMG procedures described by Stringham
et al. (2004) were used to measure photophobia thresholds for the blue and
orange targets in two well trained subjects and one naïve subject. Three
nickel-plated, surface electrodes were used to record gross potentials gen-
erated during a squint: one electrode was attached below the subject’s
right eye (test), another on the subject’s right temple (reference), and a
third on the back of the subject’s neck (ground). The electrodes were con-
nected to a Grass Instruments ampliWer (#7P3B; West Warwick, RI),
which sent the signal to a waveform computer program. As in Stringham
et al., photophobia was deWned as a signal-to-noise ratio of 4:1 on the
EMG trace lasting at least 2.5 s of the 5 s duration of the test stimulus.
The fovea and parafovea ratios obtained for the two well trained sub-
jects (Subjects 1 and 2) and one naïve subject (Subject 3) using EMG in
one session and a scaling technique in a separate session are presented in
Fig. 2. Each bar in the Wgure represents the ratio of energy necessary to
induce photophobia for the orange target versus the blue target. There was
a high degree of similarity within subjects using the two techniques. In
Subjects 1 and 2, in particular, the fovea and parafovea ratios obtained
with EMG (solid bars) were nearly identical to their respective ratios
obtained using the scaling technique (slashed bars). The diVerence in sensi-
tivity between the orange and blue targets was greatest in the parafovea
(parafovea ratio) for all three subjects regardless of the method used to
measure photophobia thresholds. The fovea ratios, in contrast to the par-
afovea ratios, markedly diVered between subjects. In Subject 1, there was
little diVerence in the energy that induced photophobia for the blue and
orange foveal targets. On the other hand, Subject 2 had the greatest diVer-
ence in threshold energy for the two targets, and unlike Subjects 1 and 3,
required more energy for the blue target than the orange target to induce
photophobia in the fovea (hence the positive ratio). Interestingly, Subject 1
had relatively low MPOD whereas Subject 2 had relatively high MPOD.
The within-subject diVerences between the EMG and scaling technique
measures were well within the test-retest variance observed in a previous
study investigating photophobia (Stringham et al., 2003), which suggests
that a scaling technique can be reliably used to determine photophobia
thresholds. Further, a psychophysical scaling procedure has two primary
advantages over EMG for determining photophobia thresholds. It is less
invasive for the subject, and more importantly, EMG can be used only to
measure squint magnitude, not the experience of visual discomfort.
Fig. 2. Foveal and parafoveal photophobia ratios for two well trained
subjects (Subjects 1 and 2) and one naïve subject (Subject 3) measured
with electromyography (Wlled bars) and a scaling technique (slashed bars).2.4. Procedure
To investigate adequately the impact of macular pigment on photo-
phobia, two experiments were performed. The objective of Experiment I
was to investigate the relationship between MPOD and the energy neces-
sary to induce photophobia for the blue target relative to the orange tar-
get. By use of the aforementioned techniques, MPOD and photophobia
thresholds were measured in 10, non-smoking Caucasians: four males and
six females, ages 21–33. The relationships between PP ratio and MPOD,
integrated macular pigment and estimated peak MPOD were analyzed by
Pearson product-moment correlations. The data are presented as means
(§SEM).
The objective of the Experiment II was to increase MPOD and mea-
sure the possible changes in the energy needed to induce photophobia.
Four subjects from Experiment I, two males and two females, ages 24–31,
consumed 60 mg of Xangold™ (Cognis Corporation, La Grange, IL) die-
tary supplement daily for 12 weeks. The dosage was equal to approxi-
mately 30 mg of free lutein and 2.7 mg of free zeaxanthin per day. During
the 12 weeks of intervention, subjects continued their regular diet. Photo-
phobia thresholds and MPOD were measured at baseline and again after 6
and 12 weeks of intervention. A randomized-block design (Kirk, 1995) was
used to measure the signiWcance of changes in MPOD, integrated macular
pigment, estimated peak MPOD, and PP ratio. For signiWcant analyses
(p < 0.05), 2 was calculated as a measure of eVect size. The use of human
subjects in this project was approved by the University of New Hampshire
Institutional Review Board and adhered to the Declaration of Helsinki.
3. Results
3.1. Experiment I
Mean MPOD (n D 10) was 0.423 (§0.04), 0.326 (§0.04),
0.186 (§0.01), and 0.065 (§0.01) at 20, 30, 1°, and 2°
eccentricity, respectively. There were no signiWcant diVer-
ences in MPOD between the males and females. Subjects’
MPOD at 20 (r D 0.767, p D 0.009), 30 (r D 0.760,
p D 0.010) and 1° (r D 0.694, p D 0.025) eccentricity were lin-
early related to PP ratio. MPOD at 2° eccentricity was not
related to PP ratio (r D ¡0.116, p D 0.750). The relationships
between MPOD at each eccentricity and PP ratio is illus-
trated in Fig. 3. Data points with like symbols represent
each of the 10 subjects. The lines represent linear Wts
applied to the data points for each retinal eccentricity.
The Gaussian function appeared to describe the sub-
jects’ MPOD proWles well according to the coeYcient of
determination (R2). The mean R2 was 0.961 (§0.04), and
ranged from 0.856 to 0.999. Peak MPOD estimated by the
Gaussian function ranged from 0.197 to 0.730, with a mean
of 0.436 (§0.05). The area under the Gaussian Wt of each
subject’s MPOD proWle, or integrated macular pigment,
ranged from 7.4 to 68.3 with a mean of 48.3 (§5.9). Both
estimated peak MPOD (r D 0.776, p D 0.008) and integrated
macular pigment (r D 0.830, p D 0.002) were positively cor-
related with PP ratio.
3.2. Experiment II
The subjects’ mean MPOD (n D 4) at baseline and after 6
and 12 weeks of lutein intervention is illustrated in Fig. 4
(error bars are SEM). Changes in MPOD signiWcantly
diVered from baseline at 20 (F D l7.35, p D 0.003, 2 D 0.73),
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p D 0.026, 2 D 0.50) eccentricity, but not at 2° eccentricity
(F D 1.71, p D 0.370). At the three central loci, a linear trend
can be used to describe the changes in MPOD (20:
F D 26.04, p D 0.014, 2 D 0.89; 30: F D 495.70, p < 0.001,
2 D 0.93; 1°: F D 11.29, p D 0.043, 2 D 0.74).
The R2 of the Gaussian Wt of the subject’s MPOD pro-
Wles at baseline ranged from 0.999 to 0.950. Interestingly,
the coeYcient of determination increased after interven-
tion. The mean R2 was 0.972 at baseline and 0.983 after
intervention. Mean integrated macular pigment increased
from 50.86 (§9.15) at baseline to 56.10 (§8.94) after six
Fig. 3. The relationships between macular pigment optical density at 20,
30, 60 (1°) and 120 eccentricity and photophobia ratio in Experiment I.
The lines represent a linear Wt of the data at each retinal eccentricity.
Fig. 4. Mean baseline, week 6, and week 12 macular pigment optical den-
sity (MPOD) at 20, 30, 60 (1°) and 120 eccentricity for the four subjects
in Experiment II. Inset shows mean photophobia ratios at baseline, 6 and
12 weeks. Error bars represent SEM.weeks of intervention, and to 60.27 (§9.74) after 12 weeks.
Integrated macular pigment signiWcantly increased from
baseline (F D 9.12, p D 0.015, 2 D 0.57) and followed a lin-
ear trend (F D 16.74, p D 0.026, 2 D 0.75). After 12 weeks of
lutein supplementation, estimated peak MPOD increased
from 0.452 (§0.11) to 0.536 (§0.11). This change signiW-
cantly diVered from baseline (F D 15.28, p D 0.004,
2 D 0.70) and appeared to be linear (F D 17.03, p D 0.003,
2 D 0.94).
In all four subjects PP ratios increased after six weeks of
intervention, and in three of the four subjects, increased
from 6 to 12 weeks. Mean PP ratio at baseline, 6 and 12
weeks is shown in Fig. 4 (inset), with the error bars repre-
senting SEM. Mean PP ratio signiWcantly increased after 12
weeks of lutein intervention (F D 10.41, p D 0.011,
2 D 0.61). As was the case for MPOD, a linear trend
appears to describe the changes in PP ratio (F D 13.09,
p D 0.036, 2 D 0.86). The relationship between changes in
integrated macular pigment and PP ratio observed in
Experiment II appear to follow the function between these
variables observed in Experiment I. Fig. 5 shows the rela-
tionships between integrated macular pigment and PP ratio
obtained in Experiment I and Experiments I and II com-
bined. The Wlled squares represent data for the six subjects
who participated exclusively in Experiment I. The addi-
tional four symbols represent the data from the four sub-
jects who participated in both Experiments; with the Wlled
symbols representing baseline (or Experiment I data), the
unWlled symbols week 6, and the stricken-through unWlled
symbols week 12. The linear relationship between PP ratio
and integrated macular pigment obtained in Experiment I
Fig. 5. Relationship between photophobia ratio (PP ratio) and integrated
macular pigment observed in Experiment I and Experiments I and II com-
bined. The data of the six subjects who participated in Experiment I are
illustrated with solid squares, whereas the data of the four subjects who
participated in both Experiments are illustrated with four diVerent sym-
bols (circle, up-triangle, down-triangle, and diamond). The solid line is a
linear Wt of the data from Experiment I, and the dotted line is a Wt of the
data from Experiments I and II combined.
4620 A.J. Wenzel et al. / Vision Research 46 (2006) 4615–4622(n D 10) is illustrated by the solid line. The dotted line shows
the linear relationship between integrated macular pigment
and PP ratio from Experiments I and II combined (n D 18).
The inclusion of data from Experiment II resulted in a
modest change in slope of the linear Wt.
Twenty-six random and 17 non-random catch trials
were performed while measuring PP ratios in both Experi-
ments. The random catch trials had a hit:FA ratio of 12:1
and the non-random catch trials had a hit:FA ratio of 7.5:1.
Catch trials were not used or reported in previous investi-
gations of photophobia; as a result, an acceptable hit:FA
ratio has not been determined. However, the hit:FA ratio
observed in the current study was suYciently high to
suggest that photophobia thresholds may be measured
reliably using the method of ascending limits and a scaling
technique.
4. Discussion
4.1. Distribution of macular pigment
The foveal distribution of macular pigment in this
small sample was similar to previous studies that used
HFP (e.g., Hammond, Wooten, & Snodderly, 1997, Burke
et al., 2005) or reXectometry (Chen, Chang, & Wu,
2001;Robson et al., 2003) to measure MPOD. Chen et al.
(2001) used a Gaussian function to describe the symmetry
and distribution of macular pigment across the fovea.
They reported that the Gaussian function provided a
good Wt for their 54 subjects’ MPOD proWles, with a mean
R2 of 0.94. Hammond et al. (1997) reported a mean R2 of
0.82 (n D 32) for the Gaussian Wts of their subjects’ MPOD
proWles. The mean Gaussian R2 for subjects in Experi-
ment I was 0.961. If the subject with extremely low MPOD
(and an uncharacteristic proWle) is removed, the mean
Gaussian R2 is 0.973. Regardless, the mean Gaussian
coeYcient of determination in the current project was
higher than those reported by Chen et al. (2001) and
Hammond et al. (1997). This Wnding may reXect reliable
subject performance or be the result of measuring a small
number of subjects with similarly distributed MPOD. A
few researchers have noted distinct diVerences among
subjects’ MPOD proWles. In about half of their 53 sub-
jects, Berendschot and van Norren (2006) found a Xank-
ing MPOD peak or ring at 42 eccentricity. Secondary
MPOD peaks were also observed by Hammond et al.
(1997) and Delori et al. (2006). In the current project
MPOD was measured inside (20 and 30) and outside
(60 and 120) the reported locus of the secondary MPOD
peak. If a measure was obtained at 42 eccentricity, the R2
for the Gaussian function in the current study may have
been lower, and more similar to those reported by Ham-
mond et al. (1997) and Chen et al. (2001). Still, the R2 for
the Gaussian functions in those studies, as well as the cur-
rent project, are suYciently high to provide a good model
of macular pigment distribution across the fovea, particu-
larly in subjects without bimodal MPOD proWles.The primary limitation of using HFP to measure MPOD
proWles is the inability to measure MPOD at 0° eccentricity.
To do so would require inWnitesimally small centrally
Wxated targets. The smallest targets that can be used that
will allow for reliable results are on the order of 12 of
visual angle. Thus, one beneWt of Wtting a MPOD proWle
with a Gaussian function is the ability to estimate a peak
MPOD. A measure of MPOD close to 0° was obtained by
Hammond et al. (1997). They measured MPOD using a
centrally Wxated 12 target and referred to this measure as
peak MPOD, although it was technically a measure of
MPOD at 6 eccentricity. They found that MPOD at 6 was
approximately 39.6% higher than MPOD at 30 eccentric-
ity. The authors also commented that a Gaussian Wt fre-
quently underestimated this peak. Chen et al. (2001) made
the same observation. The mean estimated Gaussian peak
(6 eccentricity) of subjects in Experiment I was approxi-
mately 27.8% higher than their mean MPOD at 30 eccen-
tricity. Given the relationship between MPOD at 6 and 30
eccentricity observed by Hammond et al. (1997), it appears
that the Gaussian Wt also underestimated peak MPOD in
the current project. Other nonlinear functions, such as the
Lorentzian function (Stringham et al., 2003), may provide a
better estimate of peak MPOD than the Gaussian function.
The dose of supplemental lutein used for Experiment II
was based on the Wndings of Landrum et al. (1997), who
reported that MPOD increased approximately 0.11 log
units after subjects consumed 30 mg of lutein per day for 12
weeks. In Experiment II, MPOD increased approximately
0.077 log units at 20 and 30 eccentricity, and 0.045 and
0.010 log units at 1° and 2° eccentricity, respectively. These
changes, while less than those observed by Landrum et al.,
at 45 eccentricity, are similar to interventions that used
20mg of lutein per day (Aleman et al., 2001; Duncan et al.,
2002). Aleman et al., for example, reported an increase of
0.07 log units at 10 eccentricity in normal subjects and
increases of 0.07, 0.07, 0.08, and 0.04 log units in patients
with retinitis pigmentosa and Usher syndrome at 10, 30,
60 and 120 eccentricity, respectively. Like the current
study, MPOD increased more in the central fovea than in
the eccentric fovea. This may, in part, explain the increases
in the coeYcient of determination for the Gaussian func-
tion. It also suggests that carotenoid accumulation in the
retina may be biased toward the central fovea, accumulat-
ing in a Gaussian manner.
4.2. Macular pigment optical density and photophobia
The Wndings of the current study suggest that macular
pigment plays a role in photophobia thresholds. In Experi-
ment I, there was a signiWcant linear relationship between
PP ratio and MPOD at 20, 30 and 1° eccentricity. Individ-
uals with higher MPOD at these loci required more short-
wavelength light, relative to longer wavelength light, to
reach threshold for photophobia in the fovea. In other
words, the amount of short-wavelength light Wltered by
subjects’ macular pigment was directly proportional to
A.J. Wenzel et al. / Vision Research 46 (2006) 4615–4622 4621their PP ratios. The relationship between short-wavelength
light absorption at 20 eccentricity and PP ratio was such
that a 10% change in light transmission resulted in a 0.07
change in PP ratio. The correlation between PP ratio and
MPOD was strongest for the 20 locus. Typically, individu-
als with high MPOD at central loci tend to have higher
aggregate totals of macular pigment. This relationship was
true for nine of the 10 subjects in Experiment I. The one
subject who did not Wt the correlation had relatively high
MPOD at 1° and 2° eccentricity compared to his MPOD at
20 eccentricity. Such individuals demonstrate that mea-
sures of MPOD at a single locus may not accurately esti-
mate macular pigment across the fovea (Aleman et al.,
2001; Robson et al., 2003), particularly if the subject has a
bimodal, as opposed to Gaussian, MPOD proWle. In fact,
this subject’s MPOD at 20 eccentricity was the third lowest
in the sample, but his integrated MPOD was approximately
the same as the subject with the highest MPOD at 20
eccentricity. Given the similarity in total macular pigment
screening for these two subjects, it is not surprising that
they had similar PP ratios. Stringham et al. (2004) reported
a similar Wnding. In their study, two individuals had dis-
tinctly diVerent MPOD proWles, but almost identical inte-
grated macular pigment and photophobia thresholds. This
Wnding supports the idea that photophobia thresholds are
aVected by the aggregate screening of macular pigment
across the fovea (Stringham et al., 2003, 2004). Indeed, the
correlation between PP ratio and integrated macular pig-
ment was stronger than the relationship between PP ratio
and MPOD at any single locus. This diVerence in the
strength of the correlation would undoubtedly be larger if
the sample contained more individuals with higher MPOD
at 1° and 2° eccentricity relative to 20 eccentricity.
In Experiment II, signiWcant increases in PP ratio were
observed after increasing MPOD. Although a placebo
group may have unequivocally established that PP ratios
did not simply increase over time or as a result of demand
characteristics on the part of the subjects, the linear
changes in PP ratio between baseline and week 6, and
between week 6 and week 12 corresponded directly to the
linear increases in MPOD. Both integrated MPOD and PP
ratio increased approximately 11% between baseline and
week 6. Analogous changes were observed between week 6
and week 12. Further, the function between integrated mac-
ular pigment and PP ratio observed in Experiment I pre-
dicted the changes in PP ratio observed in Experiment II, as
illustrated by the similar linear Wts in Fig. 5.
Numerous studies suggest that retinal lutein and zeaxan-
thin, or macular pigment, may protect the retina from light
induced damage. The light-Wltering properties of macular
pigment may also inXuence visual comfort. SpeciWcally, the
current project demonstrated that the macular pigment
increases the amount of light necessary to induce visual dis-
comfort, or photophobia, for short-wavelength targets.
Should this prove beneWcial, it was demonstrated that 12
weeks of lutein supplementation can signiWcantly increase
MPOD, and as a result, photophobia light thresholds.Acknowledgments
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